Lowe Brockenbrough & Co’s Biogen BIIB Stock Holding History

Lowe Brockenbrough & Co’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-750	Closed	-$214K	–	263
2023 Q2	$214K	Sell	750 -4	-0.5%	-$1.19K	0.02%	264
2023 Q1	$210K	Buy	754 +4	+0.5%	+$1.11K	0.02%	262
2022 Q4	$208K	Hold	750	–	–	0.02%	258
2022 Q3	$200K	Buy	+750	New	+$159K	0.02%	250
2021 Q4	–	Sell	-750	Closed	-$212K	–	256
2021 Q3	$212K	Hold	750	–	–	0.02%	263
2021 Q2	$260K	Hold	750	–	–	0.02%	209
2021 Q1	$210K	Buy	+750	New	+$202K	0.02%	215
2020 Q4	–	Sell	-750	Closed	-$213K	–	211
2020 Q3	$213K	Hold	750	–	–	0.03%	197
2020 Q2	$201K	Hold	750	–	–	0.03%	202
2020 Q1	$237K	Hold	750	–	–	0.04%	186
2019 Q4	$223K	Sell	750 -230	-23%	-$63.8K	0.03%	205
2019 Q3	$228K	Hold	980	–	–	0.03%	203
2019 Q2	$229K	Hold	980	–	–	0.03%	200
2019 Q1	$232K	Hold	980	–	–	0.03%	196
2018 Q4	$295K	Sell	980 -23	-2%	-$7.34K	0.05%	173
2018 Q3	$354K	Sell	1,003 -18	-2%	-$6.2K	0.05%	174
2018 Q2	$296K	Hold	1,021	–	–	0.04%	180
2018 Q1	$280K	Hold	1,021	–	–	0.04%	181
2017 Q4	$325K	Hold	1,021	–	–	0.05%	175
2017 Q3	$320K	Hold	1,021	–	–	0.05%	172
2017 Q2	$277K	Hold	1,021	–	–	0.04%	176
2017 Q1	$279K	Sell	1,021 -50	-5%	-$14.1K	0.04%	170
2016 Q4	$304K	Hold	1,071	–	–	0.05%	168
2016 Q3	$335K	Buy	+1,071	New	+$317K	0.06%	163

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Lowe Brockenbrough & Co's BIIB Position: Q3 2023 in Review

Lowe Brockenbrough & Co sold out of Biogen (BIIB) in Q3 2023, closing a stake of 750 shares — an estimated $214K sold.

Lowe Brockenbrough & Co first reported a position in BIIB in Q3 2016 and held it in 24 quarters. The position peaked at $354K in Q3 2018. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

Lowe Brockenbrough & Co reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
Lowe Brockenbrough & Co sold 750 Biogen shares in Q3 2023, an estimated $214K.
Lowe Brockenbrough & Co first reported a position in Biogen in Q3 2016 and held it in 24 quarters.
Lowe Brockenbrough & Co's Biogen position peaked at $354K in Q3 2018.
965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on Lowe Brockenbrough & Co's 13F filing for Q3 2023, filed 14 Nov 2023.